BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 174943)

  • 1. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
    Goff AK; Major PW
    FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential inhibition of cyclic AMP and cyclic GMP hydrolysis in rat renal cortex.
    Zenser TV; Craven PA; DeRubertis FR; Davis BB
    Arch Biochem Biophys; 1977 Jan; 178(2):598-606. PubMed ID: 189700
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
    Bocek RM; Beatty CH
    Dev Biol; 1976 Feb; 48(2):382-91. PubMed ID: 176071
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
    Strada SJ; Thompson WJ
    Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase activities of the human liver: comparison between control and Reye's syndrome samples.
    Kang ES
    Pediatr Res; 1978 Jul; 12(7):761-6. PubMed ID: 211480
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium and papaverine interaction with soluble cardiac phosphodiesterase.
    Carpenedo F; Gaion RM; Fassina G
    Biochem Pharmacol; 1975 Nov; 24(22):2069-73. PubMed ID: 174573
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial purification of adenosine 3',5'-cyclic monophosphate phosphodiesterases from rat pancreas in the presence of excess protease inhibitors.
    Terai M; Furihata C; Matsushima T; Sugimura T
    Arch Biochem Biophys; 1976 Oct; 176(2):621-9. PubMed ID: 185966
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterase from Spinacea oleracea L: subcellular distribution and properties [proceedings].
    Edwards M; Brown EG; Newton RP; Smith CJ
    Biochem Soc Trans; 1977; 5(4):975-7. PubMed ID: 199507
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic nucleotide phosphodiesterases associated with bovine retinal outer-segment fragments.
    Manthorpe M; McConnell DG
    Biochim Biophys Acta; 1975 Oct; 403(2):438-45. PubMed ID: 170972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP phosphodiesterase activity in Fasciola hepatica (L.) homogenates.
    Simonic T; Sartyorelli P; Locatelli A
    Ann Parasitol Hum Comp; 1975; 50(4):461-8. PubMed ID: 174476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 14. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
    Ho C; Teo TS; Desai R; Wang JH
    Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phosphodiesterase of cyclic nucleotides].
    Etingof RN; Dumler IL
    Ukr Biokhim Zh (1978); 1981; 53(2):28-43. PubMed ID: 6266102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of postsynaptically localized cyclic nucleotide phosphodiesterase.
    Ariano MA; Appleman MM
    Brain Res; 1979 Nov; 177(2):301-9. PubMed ID: 227534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
    Prasad KN; Becker G; Tripathy K
    Proc Soc Exp Biol Med; 1975 Jul; 149(3):757-62. PubMed ID: 167381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic nucleotide phosphodiesterases of Hyalophora cecropia silkmoth fat body.
    Filburn CR; Karn J; Wyatt GR
    Biochim Biophys Acta; 1977 Mar; 481(1):152-63. PubMed ID: 14689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
    Rusin LJ; Duell EA; Voorhees JJ
    J Invest Dermatol; 1978 Aug; 71(2):154-6. PubMed ID: 210235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.